The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 12, 2021
Filed:
Dec. 06, 2018
Applicant:
Poxel SA, Lyons, FR;
Inventors:
Sheila DeWitt, Auburn, NH (US);
Vincent Jacques, Somerville, MA (US);
Leonardus van der Ploeg, Newton, MA (US);
Assignee:
Poxel SA, Lyons, FR;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/4439 (2006.01); C07D 417/12 (2006.01); A61K 9/00 (2006.01); A61K 31/427 (2006.01); A61K 31/425 (2006.01); A61K 31/426 (2006.01);
U.S. Cl.
CPC ...
A61K 31/4439 (2013.01); A61K 9/0053 (2013.01); C07D 417/12 (2013.01); A61K 31/425 (2013.01); A61K 31/426 (2013.01); A61K 31/427 (2013.01);
Abstract
The invention provides enantiopure deuterium-enriched pioglitazone, pharmaceutical compositions, and methods of treating neurological disorders, cancer, respiratory disorders, metabolic disorders, and other disorders using enantiopure deuterium-enriched pioglitazone. A preferred aspect of the invention provides methods of treating Alzheimer's disease, non-small cell lung cancer, hepatocellular carcinoma, and chronic obstructive pulmonary disease using enantiopure deuterium-enriched pioglitazone.